FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2929211950> ?p ?o ?g. }

• W2929211950 endingPage "23" @default.
• W2929211950 startingPage "17" @default.
• W2929211950 abstract "Follicular dendritic cell sarcoma (FDCS) is a very rare and highly recalcitrant disease. A patient’s doxorubicin-resistant FDCS was previously established orthotopically on the right high thigh into the biceps femoris of mice to establish a patient-derived orthotopic xenograft (PDOX) model. The aim of the present manuscript was to identify an effective drug for this recalcitrant tumor. Here, we evaluated the efficacy of temozolomide (TMZ), trabectedin (TRAB) and pazopanib (PAZ) on the FDCS PDOX model. PDOX mouse models were randomized into five groups of eight to nine mice, respectively. Group 1, untreated control with PBS, i.p.; Group 2, treated with doxorubicin (DOX), 2.4 mg/kg, i.p., weekly for 3 weeks; Group 3, treated with PAZ, 50 mg/kg, oral gavage, daily for 3 weeks; Group 4, treated with TMZ, 25 mg/kg, oral gavage, daily for 3 weeks; Group 5, treated with TRAB, 0.15 mg/kg, i.v., weekly for 3 weeks. Body weight and tumor volume were assessed 2 times per week. TMZ arrested the FDCS PDOX model compared to the control group (p < 0.05). PAZ and TRAB did not have significant efficacy compared to the control group (p = 0.99, p = 0.69 respectively). The PDOX tumor was resistant to DOX (p= 0.99). as was the patient. The present study demonstrates that TMZ is effective for a PDOX model of FDCS established from a patient who failed DOX treatment, further demonstrating the power of PDOX to identify effective therapy including for tumors that failed first line therapy." @default.
• W2929211950 created "2019-04-11" @default.
• W2929211950 creator A5002607014 @default.
• W2929211950 creator A5003801834 @default.
• W2929211950 creator A5005260055 @default.
• W2929211950 creator A5009618026 @default.
• W2929211950 creator A5009960666 @default.
• W2929211950 creator A5010385761 @default.
• W2929211950 creator A5017915063 @default.
• W2929211950 creator A5020231549 @default.
• W2929211950 creator A5025137772 @default.
• W2929211950 creator A5028670925 @default.
• W2929211950 creator A5040819666 @default.
• W2929211950 creator A5059834789 @default.
• W2929211950 creator A5061431314 @default.
• W2929211950 creator A5063166399 @default.
• W2929211950 creator A5073758146 @default.
• W2929211950 creator A5084841997 @default.
• W2929211950 creator A5089307192 @default.
• W2929211950 date "2019-06-01" @default.
• W2929211950 modified "2023-09-26" @default.
• W2929211950 title "Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model" @default.
• W2929211950 cites W1569875761 @default.
• W2929211950 cites W1592125379 @default.
• W2929211950 cites W1797765963 @default.
• W2929211950 cites W1805852575 @default.
• W2929211950 cites W1830102914 @default.
• W2929211950 cites W1910239081 @default.
• W2929211950 cites W1955072209 @default.
• W2929211950 cites W1965651206 @default.
• W2929211950 cites W1969145698 @default.
• W2929211950 cites W1969705513 @default.
• W2929211950 cites W1978001125 @default.
• W2929211950 cites W1988256394 @default.
• W2929211950 cites W1993570465 @default.
• W2929211950 cites W1997855844 @default.
• W2929211950 cites W1998139955 @default.
• W2929211950 cites W2004724104 @default.
• W2929211950 cites W2015039825 @default.
• W2929211950 cites W2030277872 @default.
• W2929211950 cites W2032571910 @default.
• W2929211950 cites W2052625497 @default.
• W2929211950 cites W2056335963 @default.
• W2929211950 cites W2095556489 @default.
• W2929211950 cites W2101776780 @default.
• W2929211950 cites W2105538445 @default.
• W2929211950 cites W2117787192 @default.
• W2929211950 cites W2120672176 @default.
• W2929211950 cites W2151190143 @default.
• W2929211950 cites W2163685688 @default.
• W2929211950 cites W2169655210 @default.
• W2929211950 cites W2241685705 @default.
• W2929211950 cites W2342246138 @default.
• W2929211950 cites W2395243569 @default.
• W2929211950 cites W2419037363 @default.
• W2929211950 cites W2479746380 @default.
• W2929211950 cites W249545773 @default.
• W2929211950 cites W2500891884 @default.
• W2929211950 cites W2516251801 @default.
• W2929211950 cites W2532910614 @default.
• W2929211950 cites W2552171764 @default.
• W2929211950 cites W2580150949 @default.
• W2929211950 cites W2587201730 @default.
• W2929211950 cites W2599673208 @default.
• W2929211950 cites W2601907443 @default.
• W2929211950 cites W2604252409 @default.
• W2929211950 cites W2612864403 @default.
• W2929211950 cites W2620510751 @default.
• W2929211950 cites W2626265292 @default.
• W2929211950 cites W2626307008 @default.
• W2929211950 cites W2725885640 @default.
• W2929211950 cites W2737827748 @default.
• W2929211950 cites W2740969352 @default.
• W2929211950 cites W2742450412 @default.
• W2929211950 cites W2748387224 @default.
• W2929211950 cites W2752301033 @default.
• W2929211950 cites W2754300385 @default.
• W2929211950 cites W2770176699 @default.
• W2929211950 cites W2773499080 @default.
• W2929211950 cites W2790210280 @default.
• W2929211950 cites W2800991425 @default.
• W2929211950 cites W2810807790 @default.
• W2929211950 cites W2883508218 @default.
• W2929211950 cites W2892650490 @default.
• W2929211950 cites W2894603002 @default.
• W2929211950 cites W2898476557 @default.
• W2929211950 cites W2901337760 @default.
• W2929211950 cites W2916254412 @default.
• W2929211950 cites W347202097 @default.
• W2929211950 doi "https://doi.org/10.1016/j.tice.2019.04.002" @default.
• W2929211950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31133242" @default.
• W2929211950 hasPublicationYear "2019" @default.
• W2929211950 type Work @default.
• W2929211950 sameAs 2929211950 @default.
• W2929211950 citedByCount "6" @default.
• W2929211950 countsByYear W29292119502020 @default.
• W2929211950 countsByYear W29292119502021 @default.
• W2929211950 crossrefType "journal-article" @default.

• next